Skip to content

Sugammadex on postoperative respiratory management in children undergoing cardiac surgery

Sugammadex on postoperative respiratory management in children undergoing cardiac surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900027323
Enrollment
Unknown
Registered
2019-11-08
Start date
2019-11-01
Completion date
Unknown
Last updated
2019-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenial heart disease

Interventions

Experimental group:Sugammadex reversing postoperative neuromuscular block
Control group:normal saline

Sponsors

Shanghai Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 10 Years

Inclusion criteria

Inclusion criteria: congenial heart disease

Exclusion criteria

Exclusion criteria: respiratory infection

Design outcomes

Primary

MeasureTime frame
c response protein;

Countries

China

Contacts

Public ContactZhang Wangping

Shanghai Children's Hospital

zhang650679@163.com+86 13757370679

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026